WSIF Equity Ex-Top 100 Long-Short: construction and changes at 31 Jul 2026
Key takeaway
Listed equity: 81.06% of NAV, the largest disclosed asset allocation.
Cash equity81.06%(increased by 7.81 pp)
Top-ten cash equity31.48%(reduced by 6.73 pp)
Cash-equity rows45Prior: 35
AI Brief
What changed
Listed equity: 73.25% to 81.06% (up 7.81 percentage points). Money market: 26.50% to 1.31% (down 25.19 percentage points).
Why it matters
Equity selection is central to this portfolio. Read its sector and company concentrations alongside derivative positioning; the equity weight alone does not measure net market exposure.
What to watch
At the next comparable disclosure, check whether equity weight changes persist and whether overall long and short derivative usage changes on the same measurement basis.
What remains uncertain
Changes in holdings do not establish executed trades or the manager's intent. Derivative percentages cannot be added to asset weights. Missing figures are not zero.
Generated by Codex-authored research rules from this article and its evidence · 8 Oct 2026
OUR READING
SIFprime View
Listed equity leads at 81.06%
Equity selection is central to this portfolio. Read its sector and company concentrations alongside derivative positioning; the equity weight alone does not measure net market exposure.
Explore the evidencePORTFOLIO ALLOCATION
Latest allocation & changes
Compared with 31 May 2026 · pp = percentage points
- Listed equity
- 81.06%(increased by 7.81 pp)
- Money market
- 1.31%(reduced by 25.19 pp)
- Cash and net current assets
- 17.04%
Derivative positioning
- Futures · signed totalFutures reported %
- 0.23%
- Options · signed totalOptions valuation %
- 0.59%
Percentages are compared on the same source basis. These measures can overlap and are not added to capital allocation. Contract or short-stock rotations are not treated as company additions or removals.
Only quantified categories are shown. Missing figures are not zero; changes appear only when both disclosures are comparable.
Equity activity
61 companiesLargest weight changes in each group · % of NAV
Explore the disclosed holdings
WSIF Equity Ex-Top 100 Long-Short · 31 Jul 2026
Portfolio sleeves
Listed equitylong
45 disclosed lines
Equity movements vs 31 May 2026 · Scroll inside the table to inspect all rows. The page layout stays fixed.
| # | Security / ISIN | Sector / bucket | Weight (% NAV) | Exposure (% NAV) |
|---|---|---|---|---|
| 01 | JSW Infrastructure LimitedINE880J01026 · long Increased: 4.22% → 4.63% of NAV | Transport Infrastructure | 4.63% | 4.63% |
| 02 | HDFC Bank LimitedINE040A01034 · long Reduced: 6.91% → 4.48% of NAV | Banks | 4.48% | 4.48% |
| 03 | ICICI Prudential Life Insurance CompanyINE726G01019 · long Increased: 3.06% → 4.34% of NAV | Insurance | 4.34% | 4.34% |
| 04 | Niva Bupa Health Insurance Company Ltd.INE995S01015 · long Entries: Newly disclosed compared with the previous portfolio | Insurance | 2.95% | 2.95% |
| 05 | Balkrishna Industries LimitedINE787D01026 · long Entries: Newly disclosed compared with the previous portfolio | Auto Components | 2.79% | 2.79% |
| 06 | EUREKA FORBES LTDINE0KCE01017 · long Entries: Newly disclosed compared with the previous portfolio | Consumer Durables | 2.50% | 2.50% |
| 07 | Alkem Laboratories LimitedINE540L01014 · long Entries: Newly disclosed compared with the previous portfolio | Pharmaceuticals & Biotechnology | 2.49% | 2.49% |
| 08 | FINOLEX CABLES LTDINE235A01022 · long Entries: Newly disclosed compared with the previous portfolio | Industrial Products | 2.45% | 2.45% |
| 09 | Alembic Pharmaceuticals LimitedINE901L01018 · long Increased: 0.79% → 2.43% of NAV | Pharmaceuticals & Biotechnology | 2.43% | 2.43% |
| 10 | ICRA LIMITEDINE725G01011 · long Increased: 1.33% → 2.43% of NAV | Capital Markets | 2.43% | 2.43% |
| 11 | Syngene International LimitedINE398R01022 · long Entries: Newly disclosed compared with the previous portfolio | Healthcare Services | 2.39% | 2.39% |
| 12 | Dr. Reddy's Laboratories LimitedINE089A01031 · long Entries: Newly disclosed compared with the previous portfolio | Pharmaceuticals & Biotechnology | 2.30% | 2.30% |
| 13 | Meesho LimitedINE0VDM01015 · long Entries: Newly disclosed compared with the previous portfolio | Retailing | 2.26% | 2.26% |
| 14 | Max Financial Services LimitedINE180A01020 · long Entries: Newly disclosed compared with the previous portfolio | Insurance | 2.17% | 2.17% |
| 15 | Crompton Greaves Consumer Electrical LtdINE299U01018 · long Reduced: 3.38% → 2.12% of NAV | Consumer Durables | 2.12% | 2.12% |
| 16 | Glenmark Pharmaceuticals LimitedINE935A01035 · long Entries: Newly disclosed compared with the previous portfolio | Pharmaceuticals & Biotechnology | 1.99% | 1.99% |
| 17 | Lemon Tree Hotels LimitedINE970X01018 · long Increased: 1.90% → 1.96% of NAV | Leisure Services | 1.96% | 1.96% |
| 18 | Bayer Cropscience LimitedINE462A01022 · long Increased: 0.80% → 1.91% of NAV | Fertilizers & Agrochemicals | 1.91% | 1.91% |
| 19 | APL Apollo Tubes LimitedINE702C01027 · long Entries: Newly disclosed compared with the previous portfolio | Industrial Products | 1.88% | 1.88% |
| 20 | PTC India LimitedINE877F01012 · long Entries: Newly disclosed compared with the previous portfolio | Power | 1.84% | 1.84% |
| 21 | SWIGGY LIMITEDINE00H001014 · long Increased: 1.54% → 1.74% of NAV | Retailing | 1.74% | 1.74% |
| 22 | Eris Lifesciences LimitedINE406M01024 · long Entries: Newly disclosed compared with the previous portfolio | Pharmaceuticals & Biotechnology | 1.68% | 1.68% |
| 23 | EIH LimitedINE230A01023 · long Reduced: 2.42% → 1.65% of NAV | Leisure Services | 1.65% | 1.65% |
| 24 | BASF India LimitedINE373A01013 · long Increased: 0.77% → 1.60% of NAV | Chemicals & Petrochemicals | 1.60% | 1.60% |
| 25 | JK Lakshmi Cement LimitedINE786A01032 · long Increased: 1.41% → 1.50% of NAV | Cement & Cement Products | 1.50% | 1.50% |
| 26 | EPL LimitedINE255A01020 · long Entries: Newly disclosed compared with the previous portfolio | Industrial Products | 1.47% | 1.47% |
| 27 | Chemplast Sanmar LtdINE488A01050 · long Entries: Newly disclosed compared with the previous portfolio | Chemicals & Petrochemicals | 1.45% | 1.45% |
| 28 | Ambuja Cements LimitedINE079A01024 · long Entries: Newly disclosed compared with the previous portfolio | Cement & Cement Products | 1.43% | 1.43% |
| 29 | Chambal Fertilizers & Chemicals LimitedINE085A01013 · long Entries: Newly disclosed compared with the previous portfolio | Fertilizers & Agrochemicals | 1.36% | 1.36% |
| 30 | Blue Dart Express LimitedINE233B01017 · long Entries: Newly disclosed compared with the previous portfolio | Transport Services | 1.33% | 1.33% |
| 31 | Atul LimitedINE100A01010 · long Entries: Newly disclosed compared with the previous portfolio | Chemicals & Petrochemicals | 1.21% | 1.21% |
| 32 | Tejas Networks LimitedINE010J01012 · long Entries: Newly disclosed compared with the previous portfolio | Telecom - Equipment & Accessories | 1.19% | 1.19% |
| 33 | Dr. Lal Path Labs Ltd.INE600L01024 · long Reduced: 1.68% → 1.18% of NAV | Healthcare Services | 1.18% | 1.18% |
| 34 | INDIGO PAINTS LIMITEDINE09VQ01012 · long Reduced: 3.07% → 1.15% of NAV | Consumer Durables | 1.15% | 1.15% |
| 35 | Dalmia Bharat LimitedINE00R701025 · long Entries: Newly disclosed compared with the previous portfolio | Cement & Cement Products | 1.11% | 1.11% |
| 36 | National Aluminium Company LimitedINE139A01034 · long Entries: Newly disclosed compared with the previous portfolio | Non - Ferrous Metals | 1.08% | 1.08% |
| 37 | Brainbees Solutions Ltd.INE02RE01045 · long Entries: Newly disclosed compared with the previous portfolio | Retailing | 1.05% | 1.05% |
| 38 | JSW Cement LimitedINE718I01012 · long Reduced: 1.71% → 1.02% of NAV | Cement & Cement Products | 1.02% | 1.02% |
| 39 | Pine Labs LimitedINE15B701018 · long Entries: Newly disclosed compared with the previous portfolio | Financial Technology (Fintech) | 0.98% | 0.98% |
| 40 | Indraprastha Gas LimitedINE203G01027 · long Reduced: 1.58% → 0.94% of NAV | Gas | 0.94% | 0.94% |
| 41 | Bharat Electronics LimitedINE263A01024 · long Reduced: 2.54% → 0.80% of NAV | Aerospace & Defense | 0.80% | 0.80% |
| 42 | SAGILITY INDIA LIMITEDINE0W2G01015 · long Entries: Newly disclosed compared with the previous portfolio | IT - Services | 0.67% | 0.67% |
| 43 | Jindal Steel LimitedINE749A01030 · long Reduced: 1.58% → 0.48% of NAV | Ferrous Metals | 0.48% | 0.48% |
| 44 | Orkla India LimitedINE16NZ01023 · long Reduced: 1.52% → 0.46% of NAV | Food Products | 0.46% | 0.46% |
| 45 | Cholamandalam Invest & Finance Co LtdINE121A01024 · long Entries: Newly disclosed compared with the previous portfolio | Finance | 0.23% | 0.23% |
Exited holdings 16
Present in the previous disclosure, absent from the latest. Excluded from current holdings and sector weights.
| Company | Movement | Previous % NAV |
|---|---|---|
| ICICI Bank LimitedINE090A01021 | Exits: 5.44% in the previous disclosure | 5.44% |
| Grindwell Norton LimitedINE536A01023 | Exits: 3.42% in the previous disclosure | 3.42% |
| Honasa Consumer LimitedINE0J5401028 | Exits: 3.23% in the previous disclosure | 3.23% |
| AIA Engineering LimitedINE212H01026 | Exits: 2.93% in the previous disclosure | 2.93% |
| Lenskart Solutions LimitedINE956O01016 | Exits: 2.54% in the previous disclosure | 2.54% |
| Brigade Enterprises LimitedINE791I01019 | Exits: 2.02% in the previous disclosure | 2.02% |
| Kajaria Ceramics LimitedINE217B01036 | Exits: 1.66% in the previous disclosure | 1.66% |
| Eternal LimitedINE758T01015 | Exits: 1.64% in the previous disclosure | 1.64% |
| Alivus Life SciencesINE03Q201024 | Exits: 1.60% in the previous disclosure | 1.60% |
| CCL Products (India) LimitedINE421D01022 | Exits: 1.47% in the previous disclosure | 1.47% |
| Nuvoco Vistas Corporation LimitedINE118D01016 | Exits: 0.94% in the previous disclosure | 0.94% |
| Thyrocare Technologies LimitedINE594H01019 | Exits: 0.93% in the previous disclosure | 0.93% |
| Aditya Birla Sun Life Mutual FundINE404A01024 | Exits: 0.83% in the previous disclosure | 0.83% |
| Delhivery LimitedINE148O01028 | Exits: 0.81% in the previous disclosure | 0.81% |
| Balrampur Chini Mills LimitedINE119A01028 | Exits: 0.81% in the previous disclosure | 0.81% |
| KIRLOSKAR BROTHERS LIMITEDINE732A01036 | Exits: 0.76% in the previous disclosure | 0.76% |
Weight and exposure are separate source fields. Source signs are retained; missing values are unavailable, not zero. Derivative weights do not establish total or unhedged exposure.
The construction in context
- Listed equity: 81.06% of NAV, the largest disclosed asset allocation.
- The statement contains 4 long derivative lines. Long contracts can adjust exposure or form part of a multi-leg strategy; their purpose is not inferred from direction alone.
- The statement contains 4 short derivative lines. Short contracts can serve hedging, arbitrage or directional purposes; their presence alone does not establish a bearish view.
- JSW Infrastructure Limited (4.63% of NAV); HDFC Bank Limited (4.48% of NAV); ICICI Prudential Life Insurance Company (4.34% of NAV).
- Pharmaceuticals & Biotechnology represents 10.88% of NAV among the disclosed cash-equity lines. Unclassified sectors are excluded.
- 2 derivative lines are explicitly labelled non-hedging in the captured source. Other lines are not assigned this purpose by inference.
Movement between the actual disclosure dates
- Listed equity: 73.25% to 81.06% (up 7.81 percentage points).
- Money market: 26.50% to 1.31% (down 25.19 percentage points).
- 26 equity entries. Largest disclosed weights: Niva Bupa Health Insurance Company Ltd., Balkrishna Industries Limited, EUREKA FORBES LTD.
- 16 equity exits. Largest previous weights: ICICI Bank Limited, Grindwell Norton Limited, Honasa Consumer Limited.
- HDFC Bank Limited: 6.91% to 4.48% of NAV (reduced by 2.44 percentage points).
- INDIGO PAINTS LIMITED: 3.07% to 1.15% of NAV (reduced by 1.92 percentage points).
- Bharat Electronics Limited: 2.54% to 0.80% of NAV (reduced by 1.74 percentage points).
- Alembic Pharmaceuticals Limited: 0.79% to 2.43% of NAV (increased by 1.64 percentage points).
- Company changes cover cash equities only. Derivatives and shorts are compared by aggregate percentage on the same measurement basis. The detailed equity table contains every company change.
Reading the strategy
- Equity selection is central to this portfolio. Read its sector and company concentrations alongside derivative positioning; the equity weight alone does not measure net market exposure.
What the evidence can support
- Changes compare disclosed snapshots; they do not identify actual purchases, sales, turnover or returns.
- Derivative percentages are shown separately from asset weights. No combined gross, net-market or delta-adjusted exposure is inferred.
- A strategy interpretation describes what the holdings may imply; only an AMC statement can establish the manager's intent.
- Compared with the preceding compatible disclosure, using its actual dates.
Sources & methodology
How to read this research
- Analysis uses the captured disclosure. Portfolio dates and the report preparation date are shown separately.
- Cash-equity concentration uses long cash-equity weights. Derivatives are measured separately and are not added to allocation weights.
- Changes compare disclosed snapshots; they do not establish trade timing or manager intent. Interpretation is separate from the disclosed facts.